MOTS-c (Mitochondrial Peptide)

A Class, Not a Compound

UKPWritten and published by UK Peptides2 min readUpdated 4 cited sources

The short answer

Mitochondrial-derived peptides are short peptides encoded within the mitochondrial genome, including humanin, MOTS-c and the SHLP family. Reviews by Merry and colleagues and by Wu and colleagues survey their reported roles in energy metabolism and in diabetes.

Key facts

Known members
Humanin, MOTS-c, SHLP1-6
Encoded in
Mitochondrial DNA
Energy metabolism review
Merry 2020 (PMID 32776825)
Diabetes review
Wu 2021 (PMID 35185787)
MOTS-c review
Zheng 2023 (PMID 36761202)
Human interventional data
Absent

Why they were found late

The mitochondrial genome was considered fully annotated. Short open reading frames nested inside sequences already assigned to ribosomal RNA genes were not looked for, because there was no reason to expect them. They were found by deliberately searching for reading frames that annotation had passed over, which is why the whole class emerged within a couple of decades rather than alongside the genome itself.

What the class shares

Short length, mitochondrial encoding, and reported effects on metabolism that are broader than a peptide of that size would suggest. All were identified by sequence analysis rather than by isolating a substance responsible for an observed activity. That is the reverse of the usual route, and a reason the biology has lagged the discovery.

Research material referenced

MOTS-C 10mg, third-party HPLC tested

Buy MOTS-C · £24.99

What the reviews cover

Merry and colleagues reviewed mitochondrial-derived peptides in energy metabolism in the American Journal of Physiology in 2020. Wu and colleagues reviewed the class in diabetes and its complications in Frontiers in Endocrinology in 2021. Zheng and colleagues reviewed MOTS-c specifically in 2023 under the framing of therapeutic exploitation; the word promising in that title conveys the stage accurately.

Why review volume is not evidence quality

Several reviews of one small literature indicates interest rather than resolution. A field with settled answers produces fewer surveys, not more. Reading three reviews of the same underlying studies gives three summaries of the same evidence, and the underlying evidence for this class remains preclinical and correlational.

The question the class shares

Where these peptides are translated, and therefore what their sequence actually is in vivo. A reading frame in mitochondrial DNA read by mitochondrial ribosomes gives one peptide; the same frame read in the cytoplasm gives another, because the codes differ. That is a foundational question and it is not settled for the class.

Regulatory position

No mitochondrial-derived peptide holds a marketing authorisation from the MHRA, EMA or FDA, and none has an established human clinical programme. Material supplied here is for laboratory research only, with no claim about metabolism or any condition in any person.

Frequently asked questions

What are mitochondrial-derived peptides?

Short peptides encoded within the mitochondrial genome, including humanin, MOTS-c and the SHLP family.

Why were they discovered so recently?

They sit in short reading frames nested inside sequences already annotated as ribosomal RNA genes, so nobody was looking for them.

How strong is the evidence?

Preclinical and correlational. Several reviews of one small literature indicates interest rather than resolution.

Continue researching

Related guides and reference material.

Primary sources & clinical trials

Published papers, trial registrations, regulator pages and company announcements. Links open the original.

UKP

Written and published by UK Peptides, the trading name of AURYXRESEARCH LTD (company 17388727, registered in England and Wales).

Questions or a correction? Email hello@ukpeptides.org or call +44 7426 987848.

Corrections log

More MOTS-c (Mitochondrial Peptide) articles

Research use only. The information above is provided for scientific and educational reference. Compounds referenced are not approved for human use and are supplied for in vitro research or reference-material purposes only. No efficacy, safety, or therapeutic claims are made.